MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ene.70104

Медицинская библиотека · European journal of neurology · 2025

TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023.

Ait Tayeb Abd El Kader, Chazelas Pauline, Poinsignon Vianney, Adams David, Berthot Caroline, Cauquil Cécile, Dhaenens Claire-Marie, Francou Bruno, Jedraszak Guillaume, Labeyrie Céline, Redondo Clara Laffitte, Lia Anne-Sophie, Lopez Maureen, Proust Alexis, Sturtz Franck, Tosca Lucie, Verstuyft Céline, Echaniz-Laguna Andoni, Bouligand Jérôme

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Hereditary transthyretin amyloidosis (ATTRv) is a rare genetic disorder caused by mutations in the TTR gene. Associated with various clinical phenotypes like polyneuropathy and cardiomyopathy, ATTRv has historically had poor outcomes. Recent advances in biotherapies have significantly improved these outcomes. This study aimed to assess the evolution in genetic TTR variant screening since the advent of biotherapies in France in 2018.

METHODS

This nationwide retrospective study analyzed data and genetic results from patients who underwent TTR gene sequencing from 2018 to 2023.

RESULTS

16,640 patients were tested during the period studied. There was a 108% increase in the number of TTR gene sequencing performed annually between 2018 and 2023. Positive rates remained stable despite increased testing (7.09% over time). During this 6-year period, 1,179 patients were diagnosed with a pathogenic variant of TTR.

CONCLUSIONS

The study shows a substantial rise in TTR genetic testing in France, likely linked to the deployment of biotherapies. These findings underscore the necessity of integrating TTR gene sequencing into standard diagnostic procedures, especially given the effectiveness of treatments and the stability of positive rates.

Для цитирования: Ait Tayeb Abd El Kader, Chazelas Pauline, Poinsignon Vianney, Adams David, Berthot Caroline, Cauquil Cécile, Dhaenens Claire-Marie, Francou Bruno, Jedraszak Guillaume, Labeyrie Céline, Redondo Clara Laffitte, Lia Anne-Sophie, Lopez Maureen, Proust Alexis, Sturtz Franck, Tosca Lucie, Verstuyft Céline, Echaniz-Laguna Andoni, Bouligand Jérôme. TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023.. European journal of neurology. 2025. DOI: 10.1111/ene.70104.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.